BRT Biotechnologies
Claremont, US · Founded 2021 · Delaware corporation
Biotech
Founders & leadership
GC
Gregory CopelandExecutive
JL
Jane LiuExecutive
Reported raises · per SEC filings
Form D private placements$879.8K disclosed across 2 rounds · 2023–2025
▶$607.3KraisedMay 2026 · 12 investors · BiotechnologyRule 506(b)
▶$607.3KraisedMay 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory CopelandExecutive Officer, Director
- Jane LiuExecutive Officer, Director
- Offering amount
- $607.3K
- Amount sold
- $607.3K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$272.5KraisedOct 2023 · 7 investors · BiotechnologyRule 506(b)
▶$272.5KraisedOct 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory CopelandExecutive Officer, Director
- Jane LiuExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $272.5K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has BRT Biotechnologies raised?
- BRT Biotechnologies has disclosed $879.8K raised across 2 rounds.
- Where is BRT Biotechnologies headquartered?
- BRT Biotechnologies is headquartered in Claremont, US.